Crain's New York Business Pfizer earnings offer relief to weary investors New York Business • Dec 17, 2024
Crain's New York Business Activist investor takes $1 billion stake in Pfizer New York Business • Oct 7, 2024
New York Business Journal Pfizer to buy cancer biotech company Seagen for $43 billion New York Business • Mar 14, 2023
Daily Mail on New York Pfizer rides Paxlovid sales to better-than-expected quarter New York Non-Local Sources • Nov 1, 2022
Daily Mail on New York Pfizer's Comirnaty, Paxlovid push Q2 sales to new heights New York Non-Local Sources • Jul 28, 2022
WNYC Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5 New York City • May 23, 2022
CNN on New York Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling? New York Non-Local Sources • May 20, 2022
Daily Mail on New York Pfizer hopes to submit little-kid vaccine data by early June New York Non-Local Sources • May 3, 2022
Daily Mail on New York Pfizer tops Q1 expectations, revises 2022 forecast New York Non-Local Sources • May 3, 2022
WNYC The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids New York City • Feb 11, 2022
Brooklyn Daily Eagle Vaccines pushes Pfizer beyond expectations in final quarter New York City • Feb 8, 2022
CNN on New York Covid vaccine gives Pfizer sales and profits a big boost New York Non-Local Sources • Feb 8, 2022
CNYCentral Syracuse Upstate looking for volunteers for clinical trial on Pfizer's COVID-19 booster dose Central New York • Feb 5, 2022
CNN on New York FDA expected to broaden Pfizer Covid-19 vaccine booster eligibility to youths ages 12 to 15 in the coming days, source says New York Non-Local Sources • Dec 30, 2021
CNN on New York Albert Bourla of Pfizer is the CNN Business CEO of the Year New York Non-Local Sources • Dec 25, 2021
WNYC South African study finds Pfizer vaccine stops 70% of hospitalizations from omicron New York City • Dec 14, 2021
Finger Lakes Daily News Pfizer's COVID-19 vaccine booster shot could be available to all U.S. adults this week Finger Lakes • Nov 17, 2021
WNYC All vaccinated adults could soon be eligible for a Pfizer COVID-19 booster shot New York City • Nov 17, 2021
WNYC Pfizer agrees to license generic versions of its COVID-19 pill - in some countries New York City • Nov 16, 2021
Finger Lakes Daily News Pfizer asks FDA to allow its COVID-19 booster shot for everyone age of 18 and up Finger Lakes • Nov 10, 2021